Statements (38)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:skin
autoimmune disease |
| gptkbp:affects |
gptkb:skin
mucous membranes |
| gptkbp:antibodyTarget |
gptkb:desmoglein_1
gptkb:desmoglein_3 |
| gptkbp:causedBy |
autoantibodies
|
| gptkbp:complication |
infection
dehydration |
| gptkbp:diagnosedBy |
gptkb:ELISA
biopsy direct immunofluorescence |
| gptkbp:differentialDiagnosis |
gptkb:bullous_pemphigoid
gptkb:mucous_membrane_pemphigoid gptkb:lichen_planus |
| gptkbp:field |
immunology
dermatology |
| gptkbp:firstDescribed |
1788
|
| https://www.w3.org/2000/01/rdf-schema#label |
pemphigus vulgaris
|
| gptkbp:ICD-10_code |
L10.0
|
| gptkbp:MeSH_ID |
D010392
|
| gptkbp:mortalityRate |
potentially fatal if untreated
|
| gptkbp:namedFor |
gptkb:Willan
|
| gptkbp:OMIM |
169610
|
| gptkbp:onset |
middle-aged adults
|
| gptkbp:prevalence |
rare
|
| gptkbp:riskFactor |
genetic predisposition
certain HLA types |
| gptkbp:symptom |
blisters
painful sores oral ulcers erosions |
| gptkbp:treatment |
gptkb:rituximab
corticosteroids immunosuppressants |
| gptkbp:bfsParent |
gptkb:rituximab
gptkb:Chris_Stein |
| gptkbp:bfsLayer |
6
|